Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke

[1]  Yonghua Cui,et al.  Hydrogen Sulfide Ameliorates Early Brain Injury Following Subarachnoid Hemorrhage in Rats , 2016, Molecular Neurobiology.

[2]  N. Tyagi,et al.  Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer’s Disease-Like Pathology, Blood–Brain Barrier Disruption, and Synaptic Disorder , 2016, Molecular Neurobiology.

[3]  Jun Chen,et al.  White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke , 2015, Experimental Neurology.

[4]  X. Ji,et al.  Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model , 2015, Experimental Neurology.

[5]  J. Wallace,et al.  Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter , 2015, Nature Reviews Drug Discovery.

[6]  Ying Sun,et al.  Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux. , 2015, Biochemical and biophysical research communications.

[7]  Ying-jie Geng,et al.  Hydrogen Sulfide Inhalation Decreases Early Blood—Brain Barrier Permeability and Brain Edema Induced by Cardiac Arrest and Resuscitation , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Sherif Hafez,et al.  Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA , 2015, Translational Stroke Research.

[9]  N. Alkayed,et al.  Preclinical Evaluation of Recombinant T Cell Receptor Ligand RTL1000 as a Therapeutic Agent in Ischemic Stroke , 2015, Translational Stroke Research.

[10]  Jian Cheng,et al.  Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke , 2014, Brain, Behavior, and Immunity.

[11]  N. Alkayed,et al.  Recombinant T Cell Receptor Ligand Treatment Improves Neurological Outcome in the Presence of Tissue Plasminogen Activator in Experimental Ischemic Stroke , 2014, Translational Stroke Research.

[12]  N. Alkayed,et al.  Hydrogen sulfide protects blood–brain barrier integrity following cerebral ischemia , 2014, Journal of neurochemistry.

[13]  D. Stein,et al.  Progesterone Attenuates Hemorrhagic Transformation after Delayed tPA Treatment in an Experimental Model of Stroke in Rats: Involvement of the VEGF–MMP Pathway , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Yi-Zhun Zhu,et al.  VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. , 2013, Antioxidants & redox signaling.

[15]  J. Moser,et al.  Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. , 2013, Journal of the American Society of Nephrology : JASN.

[16]  J. Sadoshima,et al.  Thioredoxin 1 Is Essential for Sodium Sulfide–Mediated Cardioprotection in the Setting of Heart Failure , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[17]  N. Alkayed,et al.  Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke , 2013, Neuroscience.

[18]  Hong Wang,et al.  Hydrogen Sulfide Protects HUVECs against Hydrogen Peroxide Induced Mitochondrial Dysfunction and Oxidative Stress , 2013, PloS one.

[19]  Ping Cai,et al.  Recombinant ADAMTS13 reduces tissue plasminogen activator‐induced hemorrhage after stroke in mice , 2013, Annals of neurology.

[20]  M. Nicholson,et al.  Effects of hydrogen sulphide in an experimental model of renal ischaemia–reperfusion injury , 2012, The British journal of surgery.

[21]  D. Atochin,et al.  A Novel Hydrogen Sulfide-releasing N-Methyl-d-Aspartate Receptor Antagonist Prevents Ischemic Neuronal Death* , 2012, The Journal of Biological Chemistry.

[22]  Jeremy Seto,et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.

[23]  R. Swanson,et al.  Hyperglycemia promotes tissue plasminogen activator‐induced hemorrhage by Increasing superoxide production , 2011, Annals of neurology.

[24]  A. Papapetropoulos,et al.  Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function , 2011, Proceedings of the National Academy of Sciences.

[25]  J. Bian,et al.  Hydrogen sulfide: neurophysiology and neuropathology. , 2011, Antioxidants & redox signaling.

[26]  M. Whiteman,et al.  Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising , 2011, Expert review of clinical pharmacology.

[27]  Y. Zhu,et al.  Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators , 2011, Expert review of clinical pharmacology.

[28]  J. An,et al.  Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. , 2008, Blood.

[29]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[30]  O. Witte,et al.  Early Disruption of the Blood–Brain Barrier After Thrombolytic Therapy Predicts Hemorrhage in Patients With Acute Stroke , 2008, Stroke.

[31]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[32]  P. Moore,et al.  Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide , 2008, Circulation.

[33]  Sumit R. Majumdar,et al.  Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis , 2008, Diabetes Care.

[34]  L. Oesterhelweg,et al.  Phenomenological and morphological aspects of fatalities caused by manure gas , 2008 .

[35]  L. Oesterhelweg,et al.  “Death may come on like a stroke of lightening ...” , 2008, International Journal of Legal Medicine.

[36]  Csaba Szabo,et al.  Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function , 2007, Proceedings of the National Academy of Sciences.

[37]  P. Moore,et al.  Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. , 2007, Journal of applied physiology.

[38]  E. Kılıç,et al.  The phosphatidylinositol‐3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  B. Halliwell,et al.  Hydrogen Sulfide Is a Mediator of Cerebral Ischemic Damage , 2006, Stroke.

[40]  J. M. Wardlaw,et al.  Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke: Where Do We Go From Here? A Cumulative Meta-Analysis , 2003, Stroke.

[41]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[42]  B. Rosen,et al.  Rapid Breakdown of Microvascular Barriers and Subsequent Hemorrhagic Transformation After Delayed Recombinant Tissue Plasminogen Activator Treatment in a Rat Embolic Stroke Model , 2002, Stroke.

[43]  Hamid Soltanian-Zadeh,et al.  Correlation of VEGF and Angiopoietin Expression with Disruption of Blood–Brain Barrier and Angiogenesis after Focal Cerebral Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[45]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[46]  Y. Ukai,et al.  Chronic anethole trithione treatment enhances the salivary secretion and increases the muscarinic acetylcholine receptors in the rat submaxillary gland. , 1984, Archives internationales de pharmacodynamie et de therapie.